Beyond Symptom Deterioration: A Multidimensional Framework for Psychotherapy Safety
Abstract
Psychotherapy safety is often inferred from good outcomes or the absence of symptom deterioration; however, deterioration constitutes only a subset of potentially harmful treatment trajectories. While reliable symptom deterioration is an important safety signal, it does not capture the full range of psychotherapy-related harm. This article distinguishes observed adverse outcomes from treatment-attributable harm, highlighting the need for safety assessment to address harms that are symptom-invisible, delayed, cumulative, relational, ethical, or that arise from failures to adapt treatment when benefit does not emerge. The Multidimensional Psychotherapy Safety Framework (MPSF) identifies seven domains of potential harm: symptomatic and functional deterioration; negative effects of the therapeutic process; relational and dependency-related harms; harms from inappropriate treatment selection or delivery; harms from therapeutic inertia; ethical and boundary-related harms; and systemic and contextual harms. Safety evaluation across these domains should consider causal attribution, temporal course, harm through commission versus omission, and visibility to conventional symptom monitoring. These dimensions are embedded within a recursive responsiveness cycle of monitoring, recognition, interpretation, response, and re-evaluation. This paper presents clinical implications and six testable propositions to guide prospective measurement, mixed-methods research, supervision, and routine safety monitoring.
Related
- Clinical deterioration after revisiting childhood sexual abuse during psychotherapy for restrictive anorexia nervosa: a case report.
- The Role of Menstrual Cycle Phase in PTSD: A Scoping Review of Symptom Expression, Neuropsychology and Psychotherapy Response in Women
- Sudden gains and early response in routine outpatient psychotherapy: a study protocol for predicting symptom change
- Multidimensional Clinical Deterioration in Interstitial Lung Disease: Longitudinal Concordance of Frailty, Patient-Reported Outcomes, and Lung Function in a Multinational European Registry Cohort Study
- Elevated central sensitization inventory scores are associated with a multidimensional symptom profile after coronavirus disease 2019
BibTeX
@misc{holas2026beyond,
title = {{Beyond Symptom Deterioration: A Multidimensional Framework for Psychotherapy Safety}},
author = {Pawel Holas and Aleksandra Piasecka},
howpublished = {PsyArXiv},
year = {2026},
month = sep,
doi = {10.31234/osf.io/xymvh_v1},
url = {https://osf.io/preprints/psyarxiv/xymvh_v1/},
note = {CC BY 4.0},
}
RIS
TY - UNPB
TI - Beyond Symptom Deterioration: A Multidimensional Framework for Psychotherapy Safety
AU - Pawel Holas
AU - Aleksandra Piasecka
PY - 2026
DA - 2026/09/05
PB - PsyArXiv
DO - 10.31234/osf.io/xymvh_v1
UR - https://osf.io/preprints/psyarxiv/xymvh_v1/
AB - Psychotherapy safety is often inferred from good outcomes or the absence of symptom deterioration; however, deterioration constitutes only a subset of potentially harmful treatment trajectories. While reliable symptom deterioration is an important safety signal, it does not capture the full range of psychotherapy-related harm. This article distinguishes observed adverse outcomes from treatment-attributable harm, highlighting the need for safety assessment to address harms that are symptom-invisible, delayed, cumulative, relational, ethical, or that arise from failures to adapt treatment when benefit does not emerge. The Multidimensional Psychotherapy Safety Framework (MPSF) identifies seven domains of potential harm: symptomatic and functional deterioration; negative effects of the therapeutic process; relational and dependency-related harms; harms from inappropriate treatment selection or delivery; harms from therapeutic inertia; ethical and boundary-related harms; and systemic and contextual harms. Safety evaluation across these domains should consider causal attribution, temporal course, harm through commission versus omission, and visibility to conventional symptom monitoring. These dimensions are embedded within a recursive responsiveness cycle of monitoring, recognition, interpretation, response, and re-evaluation. This paper presents clinical implications and six testable propositions to guide prospective measurement, mixed-methods research, supervision, and routine safety monitoring.
ER -